BioRestorative Therapies (BRTX) Amortizatization of Intangibles (2010 - 2021)
BioRestorative Therapies' (BRTX) quarterly Amortizatization of Intangibles came in at $65041.0 in Q4 2021, up 104.24% YoY from $31844.9 in Q4 2020, and down 80.05% on a QoQ basis from $325964.0 in Q3 2021.
BioRestorative Therapies (BRTX) Amortizatization of Intangibles (2010 - 2021) Analysis & Trends
BioRestorative Therapies (BRTX) has 12 years of Amortizatization of Intangibles data on file, last reported at $65041.0 in Q4 2021.
- Quarterly Amortizatization of Intangibles rose 104.24% year-over-year to $65041.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.1 million (down 11.31% YoY) and the FY2021 annual result came in at $1.1 million, down 11.31% from the prior year.
- Amortizatization of Intangibles declined to $65041.0 in Q4 2021, from $325964.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.7 million in Q3 2020 to a low of -$2.7 million in Q4 2019.
- A 5-year average of $274253.1 and a median of $325964.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2017 — Amortizatization of Intangibles soared 1307.82% — and 2019, when it sank 759.44%.
- Tracing BRTX's Amortizatization of Intangibles over 5 years: stood at $485835.0 in 2017, then retreated by 16.54% to $405475.0 in 2018, then plunged by 759.44% to -$2.7 million in 2019, then surged by 42.67% to -$1.5 million in 2020, then soared by 104.24% to $65041.0 in 2021.
- The last three Amortizatization of Intangibles figures came in at $65041.0 (Q4 2021), $325964.0 (Q3 2021), and $325374.0 (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 65,041.00 |
| Dec 31, 2021 | 65,041.00 |
| Sep 30, 2021 | 325,964.00 |
| Sep 30, 2021 | 325,964.00 |
| Jun 30, 2021 | 325,374.00 |
| Jun 30, 2021 | 325,374.00 |
| Mar 31, 2021 | 417,160.00 |
| Mar 31, 2021 | 417,160.00 |
| Dec 31, 2020 | -1.53 Mn |
| Dec 31, 2020 | -1.53 Mn |
| Sep 30, 2020 | 1.74 Mn |
| Sep 30, 2020 | 1.74 Mn |
| Mar 31, 2020 | 1.07 Mn |
| Mar 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | -2.67 Mn |
| Dec 31, 2019 | -2.67 Mn |
| Sep 30, 2019 | 1.49 Mn |
| Sep 30, 2019 | 1.49 Mn |
| Jun 30, 2019 | 991,261.00 |
| Jun 30, 2019 | 991,261.00 |